Cargando…

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response

OBJECTIVE: Cytokines have been reported to have key roles in major depressive disorder (MDD). However, much less is known about cytokines in MDD and antidepressant treatment due to the diversity of cytokines and the heterogeneity of depression. We investigated the levels of cytokines in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myung, Woojae, Lim, Shinn-Won, Woo, Hye In, Park, Jin Hong, Shim, Sanghong, Lee, Soo-Youn, Kim, Doh Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128353/ https://www.ncbi.nlm.nih.gov/pubmed/27909456 http://dx.doi.org/10.4306/pi.2016.13.6.644

Ejemplares similares

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis
por: Woo, Hye In, et al.
Publicado: (2018)

Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response
por: Jang, Byong-Su, et al.
Publicado: (2008)

Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
por: Woo, Hye In, et al.
Publicado: (2021)

Genetic Prediction of Antidepressant Drug Response and Nonresponse in Korean Patients
por: Lim, Shinn-Won, et al.
Publicado: (2014)

Exposure–outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics
por: Kim, Jung-Ryul, et al.
Publicado: (2015)

Association between Air Pollution and Suicide in South Korea: A Nationwide Study
por: Kim, Youngdon, et al.
Publicado: (2015)

Serotonin Transporter Gene Polymorphisms and Chronic Illness of Depression
por: Myung, Woojae, et al.
Publicado: (2010)

Whole-genome sequencing reveals KRTAP1-1 as a novel genetic variant associated with antidepressant treatment outcomes
por: Park, Jong-Ho, et al.
Publicado: (2021)

Additive interaction of mid- to late-life depression and cerebrovascular disease on the risk of dementia: a nationwide population-based cohort study
por: Jang, Yoo Jin, et al.
Publicado: (2021)

Association between the BDNF Val66Met Polymorphism and Chronicity of Depression
por: Lee, Yujin, et al.
Publicado: (2013)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression
por: Zou, Wei, et al.
Publicado: (2018)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Deformities of the Globus Pallidus are Associated with Severity of Suicidal Ideation and Impulsivity in Patients with Major Depressive Disorder
por: Kim, Kiwon, et al.
Publicado: (2019)

Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder
por: Flux, Michael C., et al.
Publicado: (2023)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
por: Jung, Woo-Young, et al.
Publicado: (2016)

Prediction of Antidepressant Treatment Outcome Using Event-Related Potential in Patients with Major Depressive Disorder
por: Lee, Hyun Seo, et al.
Publicado: (2020)

White Matter Alterations Associated with Pro-inflammatory Cytokines in Patients with Major Depressive Disorder
por: Lim, Jaehwa, et al.
Publicado: (2021)

Reduced orbitofrontal-thalamic functional connectivity related to suicidal ideation in patients with major depressive disorder
por: Kim, Kiwon, et al.
Publicado: (2017)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy
por: Carta, Mauro Giovanni, et al.
Publicado: (2010)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2018)

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
por: Katona, Cornelius L, et al.
Publicado: (2014)

Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder
por: Hung, Yi-Yung, et al.
Publicado: (2015)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
por: Fontana, Andrea, et al.
Publicado: (2020)

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
por: Doruk Camsari, Deniz, et al.
Publicado: (2019)

Increased Cortical Thickness in Patients With Major Depressive Disorder Following Antidepressant Treatment
por: Nemati, Samaneh, et al.
Publicado: (2020)

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder
por: Song, Ruize, et al.
Publicado: (2021)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

Hypnic Jerks, Major Depressive Disorder, and Antidepressant Use: A Possible Relationship
por: Alghamdi, Saleh A.
Publicado: (2023)

Impact of Antidepressants on Cytokine Production of Depressed Patients in Vitro
por: Munzer, Alexander, et al.
Publicado: (2013)

Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2016)

Serum Brain-Derived Neurotrophic Factors in Taiwanese Patients with Drug-Naïve First-Episode Major Depressive Disorder: Effects of Antidepressants
por: Chiou, Yu-Jie, et al.
Publicado: (2016)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gsqpslbrqu8hlrflua6ujkc4vi